APA (7th ed.) Citation

Yuki Katayama, M., Tadaaki Yamada, M., Kenji Morimoto, M., Hiroyuki Fujii, M., Satomi Morita, M., Keiko Tanimura, M., . . . Koichi Takayama, M. (2024). Comparing Three Different Anti–Programmed Death-Ligand 1 Antibodies in Immunohistochemical Evaluation of Combined Chemoimmunotherapy Response in Patients With NSCLC: A Prospective Study. Elsevier.

Chicago Style (17th ed.) Citation

Yuki Katayama, MD, et al. Comparing Three Different Anti–Programmed Death-Ligand 1 Antibodies in Immunohistochemical Evaluation of Combined Chemoimmunotherapy Response in Patients With NSCLC: A Prospective Study. Elsevier, 2024.

MLA (9th ed.) Citation

Yuki Katayama, MD, et al. Comparing Three Different Anti–Programmed Death-Ligand 1 Antibodies in Immunohistochemical Evaluation of Combined Chemoimmunotherapy Response in Patients With NSCLC: A Prospective Study. Elsevier, 2024.